NeuroPace Inc (NPCE) Company Long-Term Loans and Borrowings

Official company branding of NeuroPace Medical (NPCE)

This price chart for NeuroPace, Inc. (NPCE) reflects the performance of a company developing unique brain stimulation systems to combat severe forms of epilepsy. However, slow physician adoption of these technologies and marketing expenses create a risk of operating losses, which currently stand at 0.07. The business relies on long-term profits from services and software updates following implant installation.

NPCE (NeuroPace Medical) Company Long-Term Debt history from 07/04/2022 to 10/28/2026

NeuroPace Corp (NPCE) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Price neuropace.com|NPCE - Price Target Chart
- market capitalization data:
Market Value NeuroPace|NPCE - Enterprise Value
- book capitalization data:
Book Value per Share NeuroPace|NPCE - Company Book Value|Market Capitalization to Net Assets neuropace.com|NPCE - Company Total Assets
- debt and liquidity data:
Debt to Capital NeuroPace, Inc.|NPCE - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital NeuroPace Medical|NPCE - Company Total Debt|Debt to Book Capital NeuroPace|NPCE - Company Long-Term Debts|Short-Term Debt Volume NeuroPace
Fundamental company analysis:NPCE (neuropace.com)
Mass-produced product of NeuroPace Corp

NeuroPace, Inc. (NPCE) maintains high margins through the precision manufacturing of neurostimulators and the optimization of global supply chains. The efficiency of this business model directly impacts the volume of borrowed funds required to scale infrastructure. This metric captures total credit obligations with maturities exceeding one year, determining the issuer's long-term solvency and financial stability. By analyzing changes in the organization's long-term financial debt, an investor can timely identify the risk of asset impairment.

Competing companies

dexcom.com - Long-Term Debt|Company Long-Term Debt Penumbra (PEN)|NOVT - Company Long-Term Loans and Borrowings|HAE: Company Long-Term Debts|INSP (Inspire Medical Systems Inc) - Company Long-Term Debts|Company Long-Term Debt PROCEPT BioRobotics PRCT|Long-Term Liabilities conmed.com|Pulse Biosciences - Company Long-Term Debts|Long-Term Debt InMode Ltd INMD|Company Long-Term Liabilities PMI (Picard Medical Inc.)|SRDX - Company Long-Term Debts|Company Long-Term Liabilities Senseonics Holdings, Inc. SENS|TCMD - Amount of Long-Term Liabilities|SANUWAVE - Company Long-Term Debts|Outset Medical Inc (OM) - Long-Term Debt Volume|Company Long-Term Debts ELMD|Company Long-Term Liabilities LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings PROF (profoundmedical.com)|Baird Medical - Company Long-Term Debt|Company Long-Term Liabilities EDAP TMS SA EDAP|APYX (Bovie Medical) - Company Long-Term Debts|ICCM - Long-Term Debt|Company Long-Term Debts pulmonx.com|TELA Bio (TELA) - Company Long-Term Indebtedness|CTSO: Company Long-Term Debts|Long-Term Debt Volume Sensus Healthcare Inc|Company Long-Term Debts ZYXI (Zynex Inc)|Company Long-Term Liabilities electrocore.com (ECOR)|Company Long-Term Debts RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Company Long-Term Debts|ICU - Company Long-Term Debt|IRIDEX Corporation (IRIX) - Company Long-Term Debt|Company Long-Term Liabilities ibs.inc INBS|Beyond Air (XAIR) - Company Long-Term Loans and Borrowings|Company Long-Term Debts PFSA (Profusa Inc)|Long-Term Debt SSKN|GCTK: Company Long-Term Debt|Long-Term Indebtedness NanoVibronix Inc. NAOV|Company Long-Term Liabilities VERO (Venus Concept Corp)|Company Long-Term Debts Nuwellis Corp NUWE|Company Long-Term Debts AEMD (Aethlon Medical)|ASXC: Long-Term Debt Volume|Company Long-Term Debt Avinger (AVGR)|BSGM (biosig.com) - Long-Term Liabilities|Company Long-Term Debt CUTR|Company Long-Term Liabilities Know Labs Corporation|Inari Medical, Inc. - Company Long-Term Debts|Long-Term Debt NVRO (nevro.com)|RSLS - Company Long-Term Debt|SILK - Company Long-Term Indebtedness